Biomedical Science Letters

eISSN 2288-7415

Table. 1. Correlation between C4orf47 gene and clinicopathological characteristics in HCC.

The clinicopathological characteristics of C4orf47 gene were analyzed using the Kaplan-Meier plotter

Clinicopathological characteristics Overall survival (n = 3,218) Relapse free survival (n = 2,809) Progression free survival (n = 3,162) Disease specific survival (n = 3,189)
N Hazard ratio P-value N Hazard ratio P-value N Hazard ratio P-value N Hazard ratio P-value
SEX
Male 246 2.23 (1.44~3.57) 0.00031 210 1.27 (0.84~1.9) 0.29 149 1.24 (0.85~1.79) 0.26 244 1.85 (1.03~3.31) 0.035
Female 118 1.14 (0.65~2.02) 0.64 106 1.91 (1.06~3.44) 0.028 121 1.86 (1.11~3.09) 0.016 118 1.63 (0.8~3.31) 0.17
STAGE
I 170 1.62 (0.87~3.03) 0.13 153 1.21 (0.68~2.16) 0.52 171 1.25 (0.73~2.14) 0.14 168 1.16 (0.43~3.08) 0.77
I+II 253 1.87 (1.15~3.03) 0.01 228 1.4 (0.91~2.16) 0.12 256 1.49 (1.01~2.2) 0.045 251 2.27 (1.13~4.53) 0.017
II 83 1.58 (0.69~3.62) 0.28 75 1.57 (0.81~3.06) 0.18 85 1.42 (0.77~2.61) 0.26 83 6.49 (1.74~24.23) 0.0015
II+III 166 1.6 (0.97~2.62) 0.62 145 1.36 (0.87~2.13) 0.17 170 1.29 (0.86~1.94) 0.22 166 2.66 (1.42~4.99) 0.0015
III 83 1.58 (0.85~2.93) 0.15 70 1.13 (0.62~2.07) 0.68 85 0.99 (0.58~1.69) 0.96 83 1.81 (0.87~3.8) 0.11
III+IV 87 1.48 (0.81~2.7) 0.2 70 1.13 (0.62~2.07) 0.68 90 1.21 (0.71~2.06) 0.49 87 1.71 (0.83~3.51) 0.14
IV 4 - - 0 - 5 - - 3 - -
GRADE
I 65 1.13 (0.32~4.08) 0.85 55 1.49 (0.44~4.66) 0.49 55 1.11 (0.41~3.0) 0.84 55 0.69 (0.08~5.54) 0.72
II 174 1.74 (1.02~2.97) 0.04 149 1.51 (0.93~2.47) 0.097 177 1.5 (0.96~2.33) 0.072 171 2.1 (1.06~4.17) 0.03
III 118 1.68 (0.92~3.07) 0.09 107 1.21 (0.71~2.07) 0.49 121 1.53 (0.92~2.55) 0.097 119 2.8 (1.31~5.99) 0.0057
IV 12 - - 11 - - 12 - - 12 - -
AJCC_T
I 180 1.7 (0.94~3.08) 0.077 160 1.27 (0.37~2.21) 0.4 181 1.29 (0.77~2.15) 0.33 178 1.35 (0.57~3.21) 0.49
II 90 1.73 (0.81~3.72) 0.15 80 1.44 (0.77~2.72) 0.25 93 1.41 (0.81~2.47) 0.23 91 5.88 (1.87~18.47) 0.00064
III 78 1.85 (0.98~3.96) 0.054 67 1.12 (0.6~2.1) 0.71 80 1.17 (0.66~2.1) 0.58 77 1.89 (0.88~4.08) 0.098
IV 13 - 6 - - 13 - - 13 - -
Vascular invasion
None 203 1.43 (0.84~2.44) 0.19 175 1.1 (0.65~1.84) 0.73 205 1.23 (0.77~1.97) 0.38 201 1.47 (0.7~3.1) 0.3
Micro 90 1.42 (0.65~3.08) 0.38 82 0.92 (0.47~1.79) 0.8 92 1.02 (0.56~1.83) 0.96 90 0.73 (0.22~2.39) 0.6
Macro 16 - - 14 - - 16 14 - -
RACE
White 181 1.25 (0.78~2.0) 0.35 147 1.22 (0.77~1.93) 0.4 184 1.37 (0.92~2.04) 0.12 179 1.51 (0.85~2.66) 0.15
Asian 154 2.31 (1.26~4.21) 0.0051 145 1.89 (1.13~3.15) 0.014 157 1.44 (0.88~2.33) 0.14 154 2.02 (0.91~4.46) 0.077
Alcohol consumption
Yes 115 2.05 (1.06~3.95) 0.029 99 1.55 (0.86~2.8) 0.14 117 1.12 (0.67~1.89) 0.66 117 2.27 (1.07~4.81) 0.029
None 202 1.67 (1.05~2.65) 0.029 183 1.64 (1.05~2.56) 0.029 205 1.76 (1.17~2.64) 0.0056 199 1.66 (0.89~3.09) 0.11
Hepatitis virus
Yes 150 2.66 (1.34~5.27) 0.0037 139 1.6 (0.95~2.69) 0.074 153 1.77 (1.1~2.86) 0.018 151 2.1 (0.88~5) 0.086
None 167 1.22 (0.78~1.91) 0.39 133 1.32 (0.8~2.17) 0.28 169 1.22 (0.79~1.89) 0.36 165 1.38 (0.79~2.42) 0.26
Biomed Sci Letters 2023;29:11-25 https://doi.org/10.15616/BSL.2023.29.1.11
© 2023 Biomed Sci Letters